By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CEL-SCI Corporation 

8229 Boone Boulevard
Suite 802
Vienna  Virginia  22182  U.S.A.
Phone: 703-506-9460 Fax: 703-506-9471


Company News
CEL-SCI (CVM) Reports Third Quarter Fiscal Year 2015 Financial Results 8/10/2015 9:57:16 AM
CEL-SCI (CVM) Reports Record Monthly Patient Enrollment In July For Its Phase III Head And Neck Cancer Trial 8/3/2015 10:13:20 AM
CEL-SCI (CVM) Expands Its Phase I Study For Treatment Of Anal Warts In HIV/HPV Co-Infected Patients With Addition Of 2nd Site At University of California, San Francisco (UCSF) 7/20/2015 10:29:12 AM
CEL-SCI (CVM) Reports June Patient Enrollment in Its Phase III Head And Neck Cancer Trial 7/1/2015 9:01:42 AM
BIO2015: CEL-SCI (CVM) To Present At The 2015 BIO International Convention 6/16/2015 11:33:15 AM
CEL-SCI (CVM) Is Cleared To Start Patient Enrollment For Its Phase III Cancer Immunotherapy Trial In Thailand 6/8/2015 10:45:52 AM
CEL-SCI (CVM) Reports May Patient Enrollment In Its Phase III Head And Neck Cancer Trial 6/1/2015 11:26:37 AM
CEL-SCI (CVM) Announces Closing Of Public Offering For Gross Proceeds Of $16 Million 5/29/2015 11:25:11 AM
CEL-SCI (CVM) To Present At The 2015 Marcum MicroCap Conference 5/27/2015 11:29:01 AM
CEL-SCI (CVM) Announces Proposed Public Offering Of Common Stock And Warrants 5/22/2015 3:37:00 PM